BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sakai H, Shirakami Y, Shimizu M. Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agents. World J Gastroenterol 2016; 22(1): 394-406 [PMID: 26755885 DOI: 10.3748/wjg.v22.i1.394]
URL: https://www.wjgnet.com/1007-9327/full/v22/i1/394.htm
Number Citing Articles
1
Ahmet E. Atay, Bennur Esen, Emel S. Gokmen. Gastrointestinal Tissue2017; : 29 doi: 10.1016/B978-0-12-805377-5.00003-5
2
Kenji Imai, Koji Takai, Tatsunori Hanai, Atsushi Suetsugu, Makoto Shiraki, Masahito Shimizu. Homeostatic Model Assessment of Insulin Resistance for Predicting the Recurrence of Hepatocellular Carcinoma after Curative TreatmentInternational Journal of Molecular Sciences 2019; 20(3): 605 doi: 10.3390/ijms20030605
3
Yohei Shirakami, Masahito Shimizu. Possible Mechanisms of Green Tea and Its Constituents against CancerMolecules 2018; 23(9): 2284 doi: 10.3390/molecules23092284
4
Kenji Imai, Koji Takai, Toshihide Maeda, Satoshi Watanabe, Tatsunori Hanai, Atsushi Suetsugu, Makoto Shiraki, Masahito Shimizu. Increased visceral fat volume raises the risk for recurrence of hepatocellular carcinoma after curative treatmentOncotarget 2018; 9(18): 14058 doi: 10.18632/oncotarget.24500
5
Rengul Cetin Atalay, Irem Durmaz. The Liver2018; : 55 doi: 10.1016/B978-0-12-803951-9.00005-7
6
Kerstin Schütte, Fathi Balbisi, Peter Malfertheiner. Prevention of Hepatocellular CarcinomaGastrointestinal Tumors 2016; 3(1): 37 doi: 10.1159/000446680
7
Daisuke Taguchi, Yohei Shirakami, Hiroyasu Sakai, Toshihide Maeda, Takao Miwa, Masaya Kubota, Kenji Imai, Takashi Ibuka, Masahito Shimizu. High-Fat Diet Delays Liver Fibrosis Recovery and Promotes Hepatocarcinogenesis in Rat Liver Cirrhosis ModelNutrients 2024; 16(15): 2506 doi: 10.3390/nu16152506
8
Basile Njei, Thomas R. McCarty, Prabin Sharma, Andrew Lange, Nilofar Najafian, Julius N. Ngu, Valmy E. Ngomba, Justin B. Echouffo-Tcheugui. Bariatric Surgery and Hepatocellular Carcinoma: a Propensity Score-Matched AnalysisObesity Surgery 2018; 28(12): 3880 doi: 10.1007/s11695-018-3431-5
9
Aleksandra Berkan-Kawińska, Anna Piekarska. Hepatocellular carcinoma in non-alcohol fatty liver disease – changing trends and specific challengesCurrent Medical Research and Opinion 2020; 36(2): 235 doi: 10.1080/03007995.2019.1683817
10
Yinshuang Chen, Weipeng Wang, Maria P. Morgan, Tracy Robson, Stephanie Annett. Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targetsFrontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1148934